| MATERIALS AND METHODS

| Ethical considerations
The Ethics Committee of Department of Surgery, Helsinki University Hospital, Helsinki, Finland approved the study (reg. no. 2270/2016).
The study conforms to Declaration of Helsinki. Patients gave written informed consent before enrolment.
| Patients
The surgeon evaluated whether a patient receiving BET was eligible for operation under MAC based on the anatomy of the nose and the patient's co-operation. Eighteen consecutive adult patients undergoing BET under MAC for dilatory or baro-challenge-induced (BCI) ETD participated in the study (Table 1) . We treated the first eight patients (five patients with dilatory ETD and three with BCI ETD) with TubaVent device. The next 10 patients (six dilatory ETD and four BCI ETD) received the operation with TubaVent short device.
The patients filled ETD questionnaire (ETDQ-7, scale 0-49) before the operation for diagnostic and demographic purposes and so that it would be possible to compare their pre-operative and postoperative symptoms at a later stage. ETDQ-7 score for the TubaVent patients was 25 ± 3 (mean ±SEM) and for the TubaVent short patients 30 ± 2. Of the two groups, 13% and 22% were smokers, respectively. Preoperatively, 50% of TubaVent and 30% of TubaVent short group had tried nasal corticosteroid treatment with insufficient results. No differences in patient characteristics appeared between the groups.
| Method
In this pilot feasibility study, we performed BET with TubaVent for the eight first consecutive patients and with TubaVent short for the next 10 consecutive patients. All patients were under local anaesthesia and received pain medication (fentanyl) and, if needed, small amounts of sedative medication (midazolam or propofol) intravenously while heart rate, blood pressure and oxygen saturation were monitored (MAC). No gross differences in intraoperative medication appeared between the groups. The patients were conscious and able to communicate with the surgeon throughout the proce- Postoperatively, the patients answered a questionnaire about their experience of BET under MAC. They answered the questionnaire separately for each side if operation was bilateral. We compared two BET devices with each other when using lidocaineprilocaine cream as local anaesthesia substance (Table 2 ) and also, in the case of bilateral BET, two local anaesthesia methods (lidocaineprilocaine cream and cocaine-adrenaline soaked in a cotton pad; Table 3 ). The bilaterally treated patients are included in both Table 2 and Table 3 .
Using TubaVent and lidocaine-prilocaine cream, maximal pain during BET was 7.0 ± 0.7 (mean ±SEM) on the visual analogue scale (VAS, 0-10) and maximal discomfort was 6.1 ± 0.8 (Table 2 ). In the 10 ETs treated with TubaVent short under lidocaine-prilocaine cream anaesthesia, the maximal pain and discomfort during BET were 4.5 ± 1.0 and 4.0 ± 0.9, respectively. This was similar to BET with TubaVent. At the time of discharge, 1-2 hours after the operation, no differences in pain and discomfort existed between the two BET devices ( Table 2) .
With lidocaine-prilocaine cream, 13% of the TubaVent patients and 30% of the TubaVent short patients felt that the operation was too uncomfortable (Table 2) . Five patients (63%) from the TubaVent group and nine (90%) treated with TubaVent short felt that pain relief was sufficient during the operation. Seven TubaVent patients (88%) and eight TubaVent short patients (80%) would choose operation under MAC and local anaesthesia with lidocaine-prilocaine cream again over general anaesthesia if they needed a reoperation later. No statistically significant differences appeared between the BET devices. We recorded the minimum and maximum heart rate during the operation as a reflection of pain and discomfort. The heart rate change from minimum to maximum heart rate was Table 2 ).
In case of bilateral treatment, we compared lidocaine-prilocaine cream with cocaine-adrenaline soaked in a cotton pad (Table 3) . No differences in outcome measures existed between the anaesthesia methods in the TubaVent group (n = 4) or in the TubaVent short group (n = 5).
Student's t-test was used in the statistical analysis of the parametric variables and chi-squared test in the analysis of the nonparametric variables. We compared the anaesthesia methods among the bilaterally treated patients from both TubaVent and TubaVent short groups, and we detected no significant differences between the anaesthesia methods or between the different catheters. CA, cocaine-adrenaline solution in a cotton pad; LP, lidocaine-prilocaine cream; SEM, standard error of the mean; VAS, visual analogue scale.
| DISCUSSION
Number of patients was small in every group in the current pilot feasibility study as well as in our previous study, 7 and that questions the relevance of the statistical analysis. Larger patient groups would be needed in future studies to confirm the current findings.
No previous studies comparing different BET and it was 40 ± 3 minutes. 7 However, the total time in the OR remained unrecorded in the current study or the previous one, neither have we studied the total time in the OR associated with BET under general anaesthesia.
As our patients still needed intravenous medication, we feel that, for the time being, BET is unsuitable as office-based procedure.
However, we envision that, in the future with improved local anaesthesia methods, the procedure could be conducted in the office. The results of this study might help a clinician in choosing suitable BET device and anaesthesia method for individualised treatment.
| CONCLUSION
No significant differences between TubaVent and TubaVent short emerged in tolerability of BET under MAC. However, pain and discomfort during BET were significantly higher in TubaVent patients than in ESS patients from our previous study. In the current study, both lidocaine-prilocaine cream and cocaine-adrenaline in a cotton pad as local anaesthesia for ET are feasible for BET when combined with nasal nerve block anaesthesia and possibility for intravenous pain medication and conscious sedation. However, room for improvement in the local anaesthesia method still exists.
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